HIV TREATMENT
2020
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
2022 Rome Action Plan on Paediatric HIV & TB
Zimbabwe Association of Church-Related Hospitals
Faith Based Organizations commit to:
153. Equip, mobilize, and support faith leaders, FBOs, people in places of worship, and the wider community to create demand for testing of infants and children.
154. Combat stigma and discrimination among faith leaders and within communities of faith.
155. Further collaborate and coordinate community mobilization, education and outreach to find otherwise hard-to-reach children, adolescents, youth and adults for age-appropriate prevention education, testing and linkage to treatment, health and social support services and integrate into the national system.
ZACT commits to:
162. Advocate for infrastructure, simplified and user-friendly diagnostic equipment provision for rural settings.
All partners commit to:
163. Address inequities by tackling the stigma and discrimination in communities, schools, and healthcare settings that prevent children living with HIV from accessing testing and treatment.
164. Increase literacy about CD4 testing and viral load and promote a client-centred approach to support expansion of access to viral load for pregnant and breastfeeding women and children on treatment, including at the point-of-care.
165. Review and assess emerging co-infections for immunocompromised infants and children, including those with advanced HIV disease, such as severe bacterial infections, fungal infections, and others for country consideration and implementation.
166. Engage affected communities for input and guidance on investment and programmatic priorities, provide support to in-country civil society organizations to engage in advocacy and demand creation for new tools, and ensure data is publicly available to support communities and civil
society to monitor progress regarding uptake and implementation of essential diagnostic tools.
-
356. Advocate and call upon all Partners who have committed to work with FBOs to honour their commitment to fully engage FBOs in HIV and TB treatment for mothers, children, young girls and adolescents.
357. Follow up on the High-Level Meeting agenda and advocate for Interfaith leadership in prioritizing major commitment for diagnostic and HIV and TB treatment working with Government (Head of States and (MoH) – Church Leadership have direct access to Heads of State and Ministers of Health to speed intervention and policy changes.
358. Advocate for capacitation of FBO Medical supplies Stores for commodity security for diagnostics and HIV/TB treatment including licensing for local production and manufacturing (MEDS, JMS, EPN and other DSOs)
359. Advocate for improved evidence-based data reporting to inform decision making, gaps analysis and financial support.
-